Closed System Transfer Devices Market to Reach USD2.67Billion by 2030 at 13.2% CAGR, Driven by Rising Safety Regulations and Oncology Needs

Mordor Intelligence has published a new report on the Closed System Transfer Devices Market offering a comprehensive analysis of trends, growth drivers, and future projections.
Introduction

According to a 2025 report by Mordor Intelligence, the Closed System Transfer Devices market size is projected to grow from USD1.43billion in2025 to USD2.67billion by2030, registering a CAGR of 13.20% over the forecast period. The Closed System Transfer Devices (CSTD) market [https://www.mordorintelligence.com/industry-reports/closed-system-transfer-devices-market?utm_source=abnewswire] plays a crucial role in enhancing safety within healthcare settings by preventing the accidental release of hazardous drugs during preparation, transport, and administration. These systems are specifically designed to prevent the escape of aerosols or vapors, reducing the risk of exposure to healthcare workers and patients alike.

Key Trends

Key Trends in the Closed System Transfer Devices Market

*
Rising Regulatory Mandates for Hazardous Drug Safety: Governments and regulatory bodies, such as the United States Pharmacopeia (USP) with its USP guidelines, are increasingly mandating the use of CSTDs in handling hazardous drugs. These regulations are driving hospitals and pharmacies to adopt CSTD systems to protect healthcare workers from exposure to harmful substances during drug preparation and administration.

*
Growth in Oncology Drug Usage: The rise in global cancer cases has led to increased use of antineoplastic (chemotherapy) drugs, many of which are highly toxic. This has created greater demand for safety mechanisms like CSTDs to ensure these drugs are handled and administered without contamination or exposure risks.

*
Adoption of Needle-less Technologies: Needle-less CSTDs are gaining popularity due to their enhanced safety profile and user convenience. These systems reduce needlestick injuries and the possibility of drug leakage, making them a preferred choice in busy hospital settings. They also align well with safety protocols that aim to minimize direct contact with hazardous medications.

*
Shifting Preference Toward Membrane-to-Membrane Devices:While needle-less systems are dominant, membrane-to-membrane devices are gaining traction due to their superior sealing and contamination control. These systems use dual membranes to create a closed pathway for drug transfer, reducing the chance of leakage during high-pressure transfers.

Market Segmentation

The CSTD market is carefully segmented by system type, closing mechanism, component, end user, and region. Each segment displays unique dynamics and opportunities:

By System Type: Needleless systems dominate, accounting for 64.3% of market revenues in 2024, driven by their ease of use and lower contamination risk. Conversely, membrane-to-membrane configurations are projected to grow at a CAGR of 14.3% through 2030.

By Closing Mechanism: Luer-Lock systems held the largest share in 2024 at 38.3%. Yet, Push-to-Turn mechanisms are the fastest-growing category, expected to expand at a CAGR of 16.1% by 2030. These emerging designs offer safer interlocks and more intuitive operation.

By Component: The market segments include syringe safety devices, vial access devices, bag access devices, and others. Syringe safety remains a core area given its critical role in injections, while vial and bag access devices gain importance for oncology protocols and parenteral solutions.

By End User: Hospitals remain the largest consumers, with oncology clinics and specialty centers showing steady growth, particularly where biologics and hazardous drugs are handled regularly.

By Geography: North America remains dominant with a 43.5% share in 2024, bolstered by regulatory push and mature healthcare systems. The Asia-Pacific region is forecast to post the fastest expansion, with a CAGR of ~15.23% between 2025 and 2030.

Key Players

*
Becton, Dickinson & Company (BD) A market leader with broad penetration, BD holds a significant share by leveraging extensive intellectual-property rights and a global distribution network. In 2024, BD completed a major acquisition (its critical-care division), reinforcing its strategy to integrate CSTDs into a fully featured medication-safety portfolio.

*
ICU Medical, Inc. ICU Medical is a top-tier provider, notable for its closed-system infusion pumps that create a locked-in ecosystem for hospital systems. This design enables the company to cross-sell CSTD components across its infusion infrastructure.

*
Equashield LLC Known for its dual-membrane CSTD designs, Equashield commands rapid uptake in facilities handling high-potency chemotherapy. This technology differentiates the company and secures a strong position within the top three vendors, which control around 65% of the total market.

*
Baxter International Inc. Baxter is recognized as one of the top six industry leaders, offering CSTD solutions alongside a well-established pharmaceutical and medical-device business line.

*
B. Braun Melsungen AG B.Braun is listed among the top players globally, benefiting from a comprehensive medical products portfolio and significant reach in both mature and emerging market.

Conclusion

Projected to nearly double in value by2030, the CSTD market is fueled by stricter safety standards, increasing chemotherapy volumes, and rising adoption of biologics. Growth is further boosted by the popularization of needle-less and membrane-based devices, while innovations in closing mechanisms enhance convenience and safety.

North America remains the primary market, supported by a robust regulatory landscape. Meanwhile, Asia-Pacific stands out as a high-growth region, backed by rising healthcare infrastructure investment and growing chronic disease rates.

Leading players maintain their edge through continuous product updates, service bundling, and strategic expansion into new geographies and application areas including veterinary and emerging economies. Given the market's trajectory, CSTD solutions will likely become standard across healthcare settings, cementing their role in healthcare safety protocols worldwide.

For More Insights: https://www.mordorintelligence.com/industry-reports/closed-system-transfer-devices-market?utm_source=abnewswire

Industry Related Reports

Infusion Management Market: [https://www.mordorintelligence.com/industry-reports/infusion-management?utm_source=abnewswire] The Infusion Management Market report segments the industry into By Product Type (Volumetric Infusion Pumps, Syringe Pumps, and Others), By Therapy Type (Antibiotics, Antimicrobial, and Others), By Application (Oncology and Others), By End User (Hospitals & Clinics and Others), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD Million) for the above segments.

Patient Lateral Transfer Devices Market: The Global Patient Lateral Transfer Market is segmented by Product Type (Air-assisted Transfer Mattresses, Slide Sheets, and Lateral Transfer Accessories), By Usage (Reusable and Disposable), By End User (Hospitals, Ambulatory Surgical Centers, and Other End Users), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World). The report offers the value (in USD Million) for the above segments.

Get More Insights: https://www.mordorintelligence.com/industry-reports/patient-lateral-transfer-devices-market?utm_source=abnewswire

Medical Suction Devices Market: [https://www.mordorintelligence.com/industry-reports/medical-suction-devices-market?utm_source=abnewswire] The Medical Suction Devices Market report is segmented by Type (AC-Powered, Battery-Powered, and Others), By Portability (Hand-Held/Portable, Wall-Mounted, and Trolley/Cart-Mounted), By Application (Airway Clearance, Surgical Applications, and Others), By End User (Hospitals, Home Healthcare Settings, and Others), and By Geography (North America, Europe, Asia-Pacific, and Others). The market forecasts are provided in terms of value (USD).

About Mordor Intelligence: Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact: media@mordorintelligence.com https://www.mordorintelligence.com/

Media Contact
Company Name: Mordor Intelligence Private Limited
Contact Person: Jignesh Thakkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=closed-system-transfer-devices-market-to-reach-usd267billion-by-2030-at-132-cagr-driven-by-rising-safety-regulations-and-oncology-needs]
Phone: +1 617-765-2493
Address:5th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli
City: Hyderabad
State: Telangana 500008
Country: India
Website: https://www.mordorintelligence.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.